Pediatric Cancer: US FDA Will Take ‘Rational’ Approach To Requiring Combination Studies

 
• By Sue Sutter
  
blue-puzzle-pieces
Figuring out how different agents fit together to treat pediatric cancers will require prioritization. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D